Literature DB >> 27273719

Influence of Ametropia and Its Correction on Measurement of Accommodation.

Paula Bernal-Molina1, Fernando Vargas-Martín2, Larry N Thibos3, Norberto López-Gil1.   

Abstract

PURPOSE: Amplitude of accommodation (AA) is reportedly greater for myopic eyes than for hyperopic eyes. We investigated potential explanations for this difference.
METHODS: Analytical analysis and computer ray tracing were performed on two schematic eye models of axial ametropia. Using paraxial and nonparaxial approaches, AA was specified for the naked and the corrected eye using the anterior corneal surface as the reference plane.
RESULTS: Assuming that axial myopia is due entirely to an increase in vitreous chamber depth, AA increases with the amount of myopia for two reasons that have not always been taken into account. First is the choice of reference location for specifying refractive error and AA in diopters. When specified relative to the cornea, AA increases with the degree of myopia more than when specified relative to the eye's first Gaussian principal plane. The second factor is movement of the eye's second Gaussian principal plane toward the retina during accommodation, which has a larger dioptric effect in shorter eyes.
CONCLUSIONS: Using the corneal plane (placed at the corneal vertex) as the reference plane for specifying accommodation, AA depends slightly on the axial length of the eye's vitreous chamber. This dependency can be reduced significantly by using a reference plane located 4 mm posterior to the corneal plane. A simple formula is provided to help clinicians and researchers obtain a value of AA that closely reflects power changes of the crystalline lens, independent of axial ametropia and its correction with lenses.

Entities:  

Mesh:

Year:  2016        PMID: 27273719     DOI: 10.1167/iovs.15-18686

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  1 in total

Review 1.  Aberrations and accommodation.

Authors:  Antonio J Del Águila-Carrasco; Philip B Kruger; Francisco Lara; Norberto López-Gil
Journal:  Clin Exp Optom       Date:  2019-07-08       Impact factor: 2.742

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.